Our guest on this episode is ⁠Mike Uchrin⁠, Co-founder and CEO of ⁠Monogram Health⁠. Founded in 2019, Monogram Health is revolutionizing kidney care through its value-based, in-home care model, improving outcomes for patients with chronic kidney disease (CKD) and end-stage kidney disease (ESKD) as well as related polychronic conditions. By integrating evidence-based clinical protocols and personalized care delivery, Monogram ensures that CKD patients receive comprehensive support directly in their homes. The company was recently recognized as the third fastest-growing privately held company in the U.S., backed by over $350 million in funding from major healthcare players like CVS Health, Cigna Ventures and Humana, among others.

In the episode, Mike and I discussed: 1)Monogram’s value-based, in-home care model for CKD and ESKD patients, 2) The importance of multispecialty care and evidence-based protocols in improving patient outcomes, 3) Challenges of scaling nationwide while maintaining care quality, and 4) Innovations in kidney care, including genetic and pharmacological breakthroughs.